After recognizing the role that BRCA1 and BRCA2 genes have in susceptibility and prognostic evaluation in breast and ovarian cancer [10,11], several works have studied the association between aberrations of DNA-repair system genes and prostate cancer [13,22,23,24]. This evidence concerns the gene BRCA2 and prostate carcinoma.